Simoons ML - Search Results

1

Predictors of stroke within 30 days in patients with non-ST-segment elevation acute coronary syndromes.

Westerhout CM, Hernández AV, Steyerberg EW, Bueno H, White H, Théroux P, Moliterno DJ, Armstrong PW, Califf RM, Wallentin LC, Simoons ML, Boersma E. Westerhout CM, et al. Among authors: simoons ml. Eur Heart J. 2006 Dec;27(24):2956-61. doi: 10.1093/eurheartj/ehl356. Epub 2006 Nov 8. Eur Heart J. 2006. PMID: 17093039

2

Effects of cardiac resynchronization therapy on overall mortality and mode of death: a meta-analysis of randomized controlled trials.

Rivero-Ayerza M, Theuns DA, Garcia-Garcia HM, Boersma E, Simoons M, Jordaens LJ. Rivero-Ayerza M, et al. Eur Heart J. 2006 Nov;27(22):2682-8. doi: 10.1093/eurheartj/ehl203. Epub 2006 Sep 11. Eur Heart J. 2006. PMID: 16966347 Review.

3

Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials.

Boersma E, Harrington RA, Moliterno DJ, White H, Théroux P, Van de Werf F, de Torbal A, Armstrong PW, Wallentin LC, Wilcox RG, Simes J, Califf RM, Topol EJ, Simoons ML. Boersma E, et al. Among authors: simoons ml. Lancet. 2002 Jan 19;359(9302):189-98. doi: 10.1016/S0140-6736(02)07442-1. Lancet. 2002. PMID: 11812552

4

Early angioplasty in acute coronary syndromes without persistent ST-segment elevation improves outcome but increases the need for six-month repeat revascularization: an analysis of the PURSUIT Trial. Platelet glycoprotein IIB/IIIA in Unstable angina: Receptor Suppression Using Integrilin Therapy.

Ronner E, Boersma E, Laarman GJ, Somsen GA, Harrington RA, Deckers JW, Topol EJ, Califf RM, Simoons ML. Ronner E, et al. Among authors: simoons ml. J Am Coll Cardiol. 2002 Jun 19;39(12):1924-9. doi: 10.1016/s0735-1097(02)01897-1. J Am Coll Cardiol. 2002. PMID: 12084589 Free article. Clinical Trial.

5

Sustained ventricular arrhythmias among patients with acute coronary syndromes with no ST-segment elevation: incidence, predictors, and outcomes.

Al-Khatib SM, Granger CB, Huang Y, Lee KL, Califf RM, Simoons ML, Armstrong PW, Van de Werf F, White HD, Simes RJ, Moliterno DJ, Topol EJ, Harrington RA. Al-Khatib SM, et al. Among authors: simoons ml. Circulation. 2002 Jul 16;106(3):309-12. doi: 10.1161/01.cir.0000022692.49934.e3. Circulation. 2002. PMID: 12119245

6

Characteristics, treatment and outcome of patients with non-ST-elevation acute coronary syndromes and multivessel coronary artery disease: observations from PURSUIT (platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrelin therapy).

Breeman A, Mercado N, Lenzen M, van den Brand MM, Harrington RA, Califf RM, Topol EJ, Simoons ML, Boersma E; PURSUIT Investigators. Breeman A, et al. Among authors: simoons ml. Cardiology. 2002;98(4):195-201. doi: 10.1159/000067321. Cardiology. 2002. PMID: 12566649 Clinical Trial.

7

Bleeding events with abciximab in acute coronary syndromes without early revascularization: An analysis of GUSTO IV-ACS.

Lenderink T, Boersma E, Ruzyllo W, Widimsky P, Ohman EM, Armstrong PW, Wallentin L, Simoons ML; GUSTO IV-ACS Investigators. Lenderink T, et al. Among authors: simoons ml. Am Heart J. 2004 May;147(5):865-73. doi: 10.1016/j.ahj.2003.11.009. Am Heart J. 2004. PMID: 15131544 Clinical Trial.

8

Dynamic prognostication in non-ST-elevation acute coronary syndromes: insights from GUSTO-IIb and PURSUIT.

Chang WC, Boersma E, Granger CB, Harrington RA, Califf RM, Simoons ML, Kleiman NS, Armstrong PW; GUSTO-IIb and PURSUIT Investigators. Chang WC, et al. Among authors: simoons ml. Am Heart J. 2004 Jul;148(1):62-71. doi: 10.1016/j.ahj.2003.05.004. Am Heart J. 2004. PMID: 15215793

9

Outcomes of patients with acute coronary syndromes and prior percutaneous coronary intervention: a pooled analysis of three randomized clinical trials.

Labinaz M, Mathias J, Pieper K, Granger CB, Lincoff AM, Moliterno DJ, Van de Werf F, Simes J, White HD, Simoons ML, Califf RM, Topol EJ, Armstrong PW, Harrington RA. Labinaz M, et al. Among authors: simoons ml. Eur Heart J. 2005 Jan;26(2):128-36. doi: 10.1093/eurheartj/ehi061. Epub 2004 Dec 9. Eur Heart J. 2005. PMID: 15618068

10

Elevated creatine kinase-MB with normal creatine kinase predicts worse outcomes in patients with acute coronary syndromes: results from 4 large clinical trials.

Galla JM, Mahaffey KW, Sapp SK, Alexander JH, Roe MT, Ohman EM, Granger CB, Armstrong PW, Harrington RA, White HD, Simoons ML, Newby LK, Califf RM, Topol EJ. Galla JM, et al. Among authors: simoons ml. Am Heart J. 2006 Jan;151(1):16-24. doi: 10.1016/j.ahj.2005.01.045. Am Heart J. 2006. PMID: 16368286

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

534 results

Search Page

Filters